Alvotech Warrant
ALVOW
13 hedge funds and large institutions have $7.22M invested in Alvotech Warrant in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.01% less ownership
Funds ownership: 2.33% → 2.32% (-0.01%)
7% less funds holding
Funds holding: 14 → 13 (-1)
61% less capital invested
Capital invested by funds: $18.6M → $7.22M (-$11.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$35.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$474 |
ALVOW Hedge Fund Activity: Q2 2023 in Review
13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Alvotech Warrant (ALVOW) for Q2 2023, worth a combined $7.22M — down 61% from $18.6M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ALVOW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Linden Advisors, cutting an estimated $35.1K.
- 13 institutional investors held Alvotech Warrant (ALVOW) as of Q2 2023, down from 14 in Q1 2023.
- Funds reported $7.22M of Alvotech Warrant stock for Q2 2023, down 61% quarter-over-quarter.
- 0 funds opened new Alvotech Warrant positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest Alvotech Warrant seller in Q2 2023 was Linden Advisors, an estimated $35.1K sold.
Based on aggregated 13F filings for Q2 2023.